JPH058192B2 - - Google Patents

Info

Publication number
JPH058192B2
JPH058192B2 JP59084234A JP8423484A JPH058192B2 JP H058192 B2 JPH058192 B2 JP H058192B2 JP 59084234 A JP59084234 A JP 59084234A JP 8423484 A JP8423484 A JP 8423484A JP H058192 B2 JPH058192 B2 JP H058192B2
Authority
JP
Japan
Prior art keywords
compound
item
dimethylamino
methyl
propanedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59084234A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59206355A (ja
Inventor
Uinton Dei Joonzu
Richaado Ee Sukunetsutoraa
Richaado Shii Daage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of JPS59206355A publication Critical patent/JPS59206355A/ja
Publication of JPH058192B2 publication Critical patent/JPH058192B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59084234A 1983-04-29 1984-04-27 新規な５−アシル−２−（１ｈ）ピリジノン類 Granted JPS59206355A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/490,081 US4568751A (en) 1983-04-29 1983-04-29 5-Acyl-2-(1H)-pyridinones
US490081 1983-04-29

Publications (2)

Publication Number Publication Date
JPS59206355A JPS59206355A (ja) 1984-11-22
JPH058192B2 true JPH058192B2 (en, 2012) 1993-02-01

Family

ID=23946554

Family Applications (2)

Application Number Title Priority Date Filing Date
JP59084234A Granted JPS59206355A (ja) 1983-04-29 1984-04-27 新規な５−アシル−２−（１ｈ）ピリジノン類
JP59084235A Granted JPS59206356A (ja) 1983-04-29 1984-04-27 新規５−アシル−２−（１ｈ）−ピリジノン類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP59084235A Granted JPS59206356A (ja) 1983-04-29 1984-04-27 新規５−アシル−２−（１ｈ）−ピリジノン類

Country Status (22)

Country Link
US (1) US4568751A (en, 2012)
EP (2) EP0124089B1 (en, 2012)
JP (2) JPS59206355A (en, 2012)
KR (2) KR900005010B1 (en, 2012)
AR (1) AR240313A1 (en, 2012)
AT (2) ATE25678T1 (en, 2012)
AU (2) AU571219B2 (en, 2012)
CA (2) CA1256880A (en, 2012)
DD (1) DD223444A5 (en, 2012)
DE (2) DE3462503D1 (en, 2012)
DK (2) DK159424C (en, 2012)
ES (2) ES531911A0 (en, 2012)
GR (2) GR81967B (en, 2012)
HU (2) HU191753B (en, 2012)
IE (2) IE57273B1 (en, 2012)
IL (2) IL71648A (en, 2012)
NO (2) NO164415C (en, 2012)
NZ (2) NZ207961A (en, 2012)
PH (1) PH20256A (en, 2012)
PT (2) PT78491B (en, 2012)
SU (1) SU1299505A3 (en, 2012)
ZA (2) ZA843033B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
US4731371A (en) * 1984-03-29 1988-03-15 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents
US5428045A (en) * 1983-04-29 1995-06-27 Merrell Dow Pharmaceuticals Inc. 5-acyl-2-(1H)-pyridinoes
US5118696A (en) * 1983-04-29 1992-06-02 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure
US4992452A (en) * 1983-04-29 1991-02-12 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure
US4853395A (en) * 1983-04-29 1989-08-01 Merrell Dow Pharmaceuticals Inc. Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4732982A (en) * 1983-11-03 1988-03-22 Merrell Dow Pharmaceuticals Inc. Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4657919A (en) * 1984-08-03 1987-04-14 E. I. Du Pont De Nemours & Co. Pyridone esters as inotropic agents
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531035A1 (de) * 1975-07-11 1977-01-27 Basf Ag Verfahren zur herstellung von 5-cyanpyridonen-(6)
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
GB1596887A (en) * 1977-07-15 1981-09-03 Rohm & Haas 2-pyridone derivatives and their use as plant growth regulators
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
DE3106460A1 (de) * 1980-03-03 1982-01-28 Sandoz-Patent-GmbH, 7850 Lörrach 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4524149A (en) * 1982-03-15 1985-06-18 Sterling Drug Inc. 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
IL71649A (en) 1987-10-30
PT78491A (en) 1984-05-01
DK159424B (da) 1990-10-15
NO164416B (no) 1990-06-25
DE3462503D1 (en) 1987-04-09
ATE25678T1 (de) 1987-03-15
IL71648A0 (en) 1984-07-31
JPS59206356A (ja) 1984-11-22
PT78493B (en) 1986-05-20
KR840008322A (ko) 1984-12-14
ZA843034B (en) 1984-11-28
IE57285B1 (en) 1992-07-15
EP0124090B1 (en) 1987-04-01
HUT34006A (en) 1985-01-28
DK159424C (da) 1991-03-18
DK213284A (da) 1984-10-30
AU2714184A (en) 1984-11-01
AU571219B2 (en) 1988-04-14
ATE26262T1 (de) 1987-04-15
NO164415C (no) 1990-10-03
NO841691L (no) 1984-10-30
EP0124089B1 (en) 1987-03-04
PH20256A (en) 1986-11-14
GR81990B (en, 2012) 1984-12-12
US4568751A (en) 1986-02-04
DE3462889D1 (de) 1987-05-07
ES8505956A1 (es) 1985-06-01
ZA843033B (en) 1984-11-28
DK213284D0 (da) 1984-04-27
CA1242443A (en) 1988-09-27
IL71649A0 (en) 1984-07-31
DK213584A (da) 1984-10-30
AU2713184A (en) 1984-11-01
KR840008323A (ko) 1984-12-14
HU191753B (en) 1987-04-28
NZ207960A (en) 1987-05-29
ES531911A0 (es) 1985-06-01
NO164416C (no) 1990-10-03
ES531910A0 (es) 1985-06-01
KR900005011B1 (ko) 1990-07-16
EP0124090A1 (en) 1984-11-07
DK159425C (da) 1991-03-18
SU1299505A3 (ru) 1987-03-23
HUT34007A (en) 1985-01-28
DK213584D0 (da) 1984-04-27
EP0124089A1 (en) 1984-11-07
IE841046L (en) 1984-10-29
IL71648A (en) 1987-11-30
JPS59206355A (ja) 1984-11-22
DK159425B (da) 1990-10-15
HU191928B (en) 1987-04-28
DD223444A5 (de) 1985-06-12
CA1256880A (en) 1989-07-04
NO164415B (no) 1990-06-25
AR240313A1 (es) 1990-03-30
PT78493A (en) 1984-05-01
PT78491B (en) 1986-05-22
IE841047L (en) 1984-10-29
ES8505955A1 (es) 1985-06-01
KR900005010B1 (ko) 1990-07-16
NO841690L (no) 1984-10-30
JPH0579668B2 (en, 2012) 1993-11-04
AU557543B2 (en) 1986-12-24
NZ207961A (en) 1986-09-10
GR81967B (en, 2012) 1984-12-12
IE57273B1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
CH619936A5 (en, 2012)
CA2648003A1 (en) Orally bioavailable caffeic acid related anticancer drugs
US4673675A (en) 1-(2-pyridyl) 4-cycloalkylmethyl piperazines having cardiotropic activity
JPH058192B2 (en, 2012)
US4853395A (en) Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
EP0316279A2 (de) Veresterte azacyclische Hydroxyverbindungen
US4731371A (en) Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents
JP3712529B2 (ja) ３，３−ジピリジルアクリル酸アミド誘導体又はその薬学的に許容される塩
EP0274524A1 (en) Pyridone-pyridyl-imidazolyl and triazolyl compounds and their use as cardiotonic agents
HU197004B (en) Process for producing cardiotonic pyridinyl-carbonyl-thiazolone derivatives
US4992452A (en) Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure
JP2640671B2 (ja) 強心三環式オキサゾロン類
KR102640385B1 (ko) 고혈압 및/또는 폐 섬유증 치료용 조성물
HU206880B (en) Process for producing oxazolone derivatives and pharmaceutical compositions containing them
JPH0465810B2 (en, 2012)
US5118696A (en) 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure
US4925857A (en) Pyridinyl-1H-pyrazole-1-alkanamides as antiarrhythmic agents
US5428045A (en) 5-acyl-2-(1H)-pyridinoes
NL8700742A (nl) 5-fluoruracilderivaat, werkwijze voor de bereiding daarvan; werkwijze voor de bereiding van een farmaceutisch preparaat met kankerbestrijdende werking alsmede toepassing van een 5-fluoruracilderivaat ter bereiding van een farmaceutisch preparaat met kankerbestrijdende werking.
JPH06157483A (ja) １，３，４−ベンゾトリアゼピン−５（４ｈ）−オン誘導体およびその製造法
EP0463407B1 (en) Use of dihydropyridins in cardiotonic pharmaceutical compositions
HU193464B (en) Process for production of alcoxi-imino-esther derivatives of 5-acryl-2/1h/-piridinon and medical preparatives containing thereof as active substance
JPH0510343B2 (en, 2012)
JPH053868B2 (en, 2012)